Intellectual property strategy in bioinformatics and biochips.
Intellectual property rights are essential in today's technology-driven age. A strong intellectual property protection strategy is crucial in the bioinformatics and biochips technology spaces as monetary and temporal resources are tremendous in finding a blockbuster drug or gene therapy, as well as in deploying advanced biosensor and other medical systems. Current problems and intellectual property practice in the genomic space are presented and analyzed. Various strategy and solutions are proposed to guide bioinformatic and biochip companies in forming an aggressive strategy to protect one's intellectual property and competitive positioning.
Fernandez
Dennis
D
Fernandez & Associates LLP, 1047 El Camino Real, Suite 201, Menlo Park, CA 94025, USA. monica@iploft.com
Chow
Mary
M
D019295:Computational Biology / Q000941:ethics / Q000331:legislation & jurisprudence; D006801:Humans; D018973:Intellectual Property; D020411:Oligonucleotide Array Sequence Analysis / Q000941:ethics; D040081:Protein Array Analysis / Q000941:ethics